These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20193126)
1. Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells. Park YJ; Lee H; Lee JH BMB Rep; 2010 Feb; 43(2):91-6. PubMed ID: 20193126 [TBL] [Abstract][Full Text] [Related]
2. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Kim KK; Lee JJ; Yang Y; You KH; Lee JH Carcinogenesis; 2008 Apr; 29(4):704-12. PubMed ID: 18258606 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850 [TBL] [Abstract][Full Text] [Related]
4. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity. Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655 [TBL] [Abstract][Full Text] [Related]
5. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Faivre EJ; Lange CA Mol Cell Biol; 2007 Jan; 27(2):466-80. PubMed ID: 17074804 [TBL] [Abstract][Full Text] [Related]
6. Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK. Cuadrado A; Garcia-Fernandez LF; Gonzalez L; Suarez Y; Losada A; Alcaide V; Martinez T; Fernandez-Sousa JM; Sanchez-Puelles JM; Munoz A J Biol Chem; 2003 Jan; 278(1):241-50. PubMed ID: 12414812 [TBL] [Abstract][Full Text] [Related]
7. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation. Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study. Jabbarzadeh Kaboli P; Leong MP; Ismail P; Ling KH Pharmacol Rep; 2019 Feb; 71(1):13-23. PubMed ID: 30343043 [TBL] [Abstract][Full Text] [Related]
9. c-Src-p38 mitogen-activated protein kinase signaling is required for Akt activation in response to ionizing radiation. Kim MJ; Byun JY; Yun CH; Park IC; Lee KH; Lee SJ Mol Cancer Res; 2008 Dec; 6(12):1872-80. PubMed ID: 19074832 [TBL] [Abstract][Full Text] [Related]
10. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells. Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134 [TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate mediates ICAM-1-dependent monocyte adhesion through p38 MAPK and p42/p44 MAPK-dependent Akt activation. Lin CC; Lee IT; Hsu CH; Hsu CK; Chi PL; Hsiao LD; Yang CM PLoS One; 2015; 10(3):e0118473. PubMed ID: 25734900 [TBL] [Abstract][Full Text] [Related]
12. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis. Tan M; Li P; Klos KS; Lu J; Lan KH; Nagata Y; Fang D; Jing T; Yu D Cancer Res; 2005 Mar; 65(5):1858-67. PubMed ID: 15753384 [TBL] [Abstract][Full Text] [Related]
13. Thrombin Enhanced Matrix Metalloproteinase-9 Expression and Migration of SK-N-SH Cells via PAR-1, c-Src, PYK2, EGFR, Erk1/2 and AP-1. Yang CC; Hsiao LD; Yang CM; Lin CC Mol Neurobiol; 2017 Jul; 54(5):3476-3491. PubMed ID: 27181591 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904 [TBL] [Abstract][Full Text] [Related]
15. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1. Bhowmik T; Gomes A Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778 [TBL] [Abstract][Full Text] [Related]
17. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells. Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604 [TBL] [Abstract][Full Text] [Related]
19. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163 [TBL] [Abstract][Full Text] [Related]
20. Src tyrosine kinase mediates endothelin-1-induced early growth response protein-1 expression via MAP kinase-dependent pathways in vascular smooth muscle cells. Simo-Cheyou ER; Vardatsikos G; Srivastava AK Int J Mol Med; 2016 Dec; 38(6):1879-1886. PubMed ID: 27748819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]